Table 1.
Baseline Characteristics of PREDICT Participants
| All (n = 445) | Men (n = 213) | Women (n = 232) | p Value | |
|---|---|---|---|---|
| Demographics | ||||
| Age (y) | 69±8 | 69±8 | 69±8 | 1.00 |
| 55–64 | 129 (36%) | 77 (36%) | 75 (32%) | .42 |
| 65–74 | 126 (35%) | 68 (32%) | 93 (40%) | .08 |
| 75+ | 106 (30%) | 68 (32%) | 64 (36%) | .35 |
| Race | ||||
| Caucasian | 293 (79%) | 182 (85%) | 171 (74%) | .002 |
| Black | 70 (19%) | 25 (12%) | 56 (24%) | .001 |
| Hispanic | 5 (1%) | 2 (0.9%) | 4 (2%) | .69 |
| Other | 4 (1%) | 4 (1.9%) | 1 (0.4%) | .20 |
| Body mass index (kg/m2) | 30±6 | 30±5 | 31±7 | 1.00 |
| Historical data | ||||
| Coronary artery disease | 121 (27%) | 83 (39%) | 38 (16%) | <.001 |
| Diabetes mellitus | 172 (39%) | 86 (40%) | 86 (37%) | .50 |
| Hypertension | 408 (92%) | 191 (90%) | 217 (94%) | .17 |
| Dyslipidemia | 230 (52%) | 107 (50%) | 123 (53%) | .57 |
| Smoker | 196 (44%) | 106 (50%) | 90 (39%) | .02 |
| Selected medications | ||||
| β-Blocker | 182 (41%) | 87 (41%) | 95 (41%) | 1.00 |
| Calcium-channel blocker | 125 (28%) | 62 (29%) | 63 (27%) | .67 |
| Nitrate | 24 (5%) | 11 (5%) | 13 (6%) | 1.00 |
| ACE inhibitor/ARB | 318 (71%) | 150 (70%) | 168 (72%) | .67 |
| Statin | 339 (76%) | 164 (77%) | 175 (75%) | .74 |
| Resting SBP, mm Hg | 141±18 | 141±16 | 142±19 | .55 |
| Resting DBP, mm Hg | 79±13 | 81±12 | 77±13 | .001 |
| Resting heart rate, bpm | 65±11 | 63±10 | 66±11 | .003 |
Note: Values are expressed as mean ± standard deviation or percent (%). ACE = angiotensin-converting enzyme; ARB = angiotensin receptor blocker; bpm = beats per minute; DBP = diastolic blood pressure; PREDICT = Pulmonary Edema and Stiffness of the Vascular System; SBP = systolic blood pressure.